通过抑制MiT-TFE转录因子,LRRK2抑制了巨细胞和微质细胞中的溶酶体降解活性
Narayana Yadavalli1,2,3,4,5, Shawn M Ferguson1,2,3,4,5,6
1Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06510.
概括
帕金森病蛋白LRRK2通过调节 lysosome活动来抑制细胞废物处理. 抑制LRRK2可以增强溶酶体功能,这表明LRRK2的过活性可能会增加帕金森病的风险.
科学领域:
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
背景情况:
- 细胞需要最佳的溶酶体功能来清除废物,防御病原体和产生营养.
- 溶解体是关键的器官,参与细胞平衡和降解.
- 功能失调的溶解体与各种疾病有关,包括神经退行性疾病.
研究的目的:
- 研究丰富于白的重复激酶2 (LRRK2) 在调节 lysosome 降解活性中的作用.
- 阐明LRRK2控制 lysosomal 功能的分子机制.
- 探索LRRK2在帕金森病病原发生的溶酶体活性中的作用.
主要方法:
- 利用细胞模型 (巨细胞和微质细胞) 来研究LRRK2的功能.
- 操纵LRRK2水平和激酶活性 (帕金森病突变体的消耗,抑制和表达).
- 评估了 lysosomal 蛋白质分解活性,lysosomal 酶基因表达和转录因子局部化.
主要成果:
- 通过转录控制,LRRK2通过转录控制负面调节 lysosome 降解活性.
- 消耗或抑制LRRK2增强了溶酶体活性和酶表达.
- 与帕金森病相关的LRRK2 G2019S突变抑制了溶酶体活性和基因表达.
- MiT-TFE转录因子 (TFE3,TFEB,MITF) 中介于LRRK2对溶酶体基因表达的控制.
- LRRK2影响了MiT-TFE因子的丰富性和核定位.
结论:
- LRRK2在控制 lysosome 降解活性方面发挥着重要作用.
- 正如在帕金森病中所见的LRRK2过活,可能会通过损害 lysosomal 功能增加疾病风险.
- 这项研究发现了一种新的机制,将LRRK2与 lysosomal homeostasis和帕金森病联系起来.
更多相关视频
11:31Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
10.1K
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.6K
相关概念视频
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:15Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K